• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叶状肿瘤:30例临床病理及免疫组织化学研究

Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.

作者信息

Esposito Nicole Nicosia, Mohan Deepak, Brufsky Adam, Lin Yan, Kapali Malathy, Dabbs David J

机构信息

Department of Pathology, University of Pittsburgh, Pittsburgh, Pa 15213, USA.

出版信息

Arch Pathol Lab Med. 2006 Oct;130(10):1516-21. doi: 10.5858/2006-130-1516-PTACAI.

DOI:10.5858/2006-130-1516-PTACAI
PMID:17090194
Abstract

CONTEXT

Phyllodes tumors (PTs) of the breast are biphasic neoplasms composed of epithelium and a spindle-cell stroma. Currently, PTs are classified as benign, borderline, or malignant based on histopathologic features. However, histologic classification does not always predict outcome. Objective.-To determine the prognostic value of a variety of clinicopathologic features and immunoreactivities in PTs.

DESIGN

Sixteen benign, 8 borderline, and 6 malignant PTs with follow-up were examined for reactivity across a panel of immunohistochemical stains, including c-Kit, endothelin 1, p16, p21, p53, and Ki-67. Clinicopathologic features, including stromal cellularity, mitotic rate, and margin status, were also assessed. Tumor variables were compared among tumor subgroups and between tumors that did and did not recur.

RESULTS

Of the 30 PTs, 4 recurred (1 benign, 2 borderline, 1 malignant). One patient with a malignant tumor died of metastatic disease 34 months after initial diagnosis. The overall positive rate of c-Kit immunoreactivity was 13% in benign, 63% in borderline, and 67% in malignant PTs. Endothelin 1 epithelial cytoplasmic staining was seen in 100% of benign, 50% of borderline, and 17% of malignant PTs. Additionally, p16, p21, p53, and Ki-67 were differentially expressed among benign, borderline, and malignant tumors. Positive surgical resection margins was the only variable that significantly predicted recurrent disease (P = .02).

CONCLUSIONS

Stromal c-Kit positivity and epithelial endothelin 1 negativity are more often associated with malignant PTs; however, only positive margin status is significantly associated with tumor behavior.

摘要

背景

乳腺叶状肿瘤(PTs)是由上皮和梭形细胞间质组成的双相性肿瘤。目前,PTs根据组织病理学特征分为良性、交界性或恶性。然而,组织学分类并不总能预测预后。目的:确定多种临床病理特征和免疫反应性在PTs中的预后价值。

设计

对16例良性、8例交界性和6例恶性且有随访资料的PTs进行一组免疫组织化学染色反应检测,包括c-Kit、内皮素1、p16、p21、p53和Ki-67。还评估了临床病理特征,包括间质细胞密度、有丝分裂率和切缘状态。比较肿瘤亚组之间以及复发和未复发肿瘤之间的肿瘤变量。

结果

30例PTs中,4例复发(1例良性、2例交界性、1例恶性)。1例恶性肿瘤患者在初次诊断后34个月死于转移性疾病。c-Kit免疫反应性的总体阳性率在良性PTs中为13%,交界性PTs中为63%,恶性PTs中为67%。内皮素1上皮细胞质染色在100%的良性PTs、50%的交界性PTs和17%的恶性PTs中可见。此外,p16、p21、p53和Ki-67在良性、交界性和恶性肿瘤中表达存在差异。手术切缘阳性是唯一能显著预测复发性疾病的变量(P = 0.02)。

结论

间质c-Kit阳性和上皮内皮素1阴性更常与恶性PTs相关;然而,只有切缘阳性状态与肿瘤行为显著相关。

相似文献

1
Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.叶状肿瘤:30例临床病理及免疫组织化学研究
Arch Pathol Lab Med. 2006 Oct;130(10):1516-21. doi: 10.5858/2006-130-1516-PTACAI.
2
Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.乳腺叶状肿瘤中p53、Ki-67和c-erbB-2的免疫反应性与临床及形态学特征的相关性
J Surg Oncol. 2002 Feb;79(2):86-92. doi: 10.1002/jso.10049.
3
p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes.p53和Ki-67表达作为叶状囊肉瘤的预后因素
Breast J. 2002 Jan-Feb;8(1):38-44. doi: 10.1046/j.1524-4741.2002.08008.x.
4
Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.乳腺叶状肿瘤的外科治疗:172例回顾性分析
J Surg Oncol. 2005 Sep 1;91(3):185-94. doi: 10.1002/jso.20334.
5
2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.2005年加洛韦纪念讲座:乳腺叶状肿瘤——形态学及其他
Ann Acad Med Singap. 2005 Dec;34(11):671-7.
6
Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.p53和MIB-1表达与乳腺叶状肿瘤患者全身复发及生存情况的相关性
Pathol Res Pract. 2006;202(10):705-12. doi: 10.1016/j.prp.2006.05.006. Epub 2006 Aug 2.
7
p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.p53和c-kit(CD117)蛋白表达作为乳腺叶状肿瘤的预后指标:一项组织芯片研究
Mod Pathol. 2005 Dec;18(12):1527-34. doi: 10.1038/modpathol.3800488.
8
Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.乳腺良/交界性叶状肿瘤的外科治疗的长期疗效。
Ann Surg Oncol. 2019 Jul;26(7):2136-2143. doi: 10.1245/s10434-019-07210-4. Epub 2019 Feb 19.
9
Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.EMP1、EMP2 和 EMP3 在乳腺叶状肿瘤中的表达。
PLoS One. 2020 Aug 28;15(8):e0238466. doi: 10.1371/journal.pone.0238466. eCollection 2020.
10
Importance of P53, Ki-67 expression in the differential diagnosis of benign/malignant phyllodes tumors of the breast.P53、Ki-67表达在乳腺良恶性叶状肿瘤鉴别诊断中的重要性。
Indian J Pathol Microbiol. 2013 Apr-Jun;56(2):129-34. doi: 10.4103/0377-4929.118690.

引用本文的文献

1
A Comparative Study on Copy Number Variation in Subtypes of Breast Phyllodes Tumors.乳腺叶状肿瘤各亚型拷贝数变异的比较研究
Breast Cancer (Auckl). 2025 Apr 12;19:11782234251329209. doi: 10.1177/11782234251329209. eCollection 2025.
2
Phyllodes tumor in the mammary gland of a northern tree shrew (Tupaia belangeri).北树鼩(笔尾树鼩)乳腺中的叶状肿瘤。
J Vet Med Sci. 2025 Apr 1;87(4):384-388. doi: 10.1292/jvms.24-0444. Epub 2025 Feb 17.
3
Evaluation of the Clinicopathological Features Associated With Malignancy of Phyllodes Tumor of the Breast.
乳腺叶状肿瘤恶性相关临床病理特征的评估
Cureus. 2024 Dec 22;16(12):e76221. doi: 10.7759/cureus.76221. eCollection 2024 Dec.
4
Breast phyllodes tumour with epithelioid feature predisposes to malignant transformation.具有上皮样特征的乳腺叶状肿瘤易发生恶性转化。
J Clin Pathol. 2025 May 25;78(6):390-398. doi: 10.1136/jcp-2024-209489.
5
Malignant Phyllodes Tumors of the Breast With Rhabdomyosarcomatous Differentiation: A Case Report and Literature Review.伴横纹肌肉瘤分化的乳腺恶性叶状肿瘤:1例报告及文献复习
Cureus. 2024 Jul 11;16(7):e64361. doi: 10.7759/cureus.64361. eCollection 2024 Jul.
6
Clinicopathological Parameters Predicting Malignancy in Phyllodes Tumor of the Breast.预测乳腺叶状肿瘤恶性程度的临床病理参数
Cureus. 2023 Sep 28;15(9):e46168. doi: 10.7759/cureus.46168. eCollection 2023 Sep.
7
Clinical perspectives and outcomes of the giant breast phyllodes tumor and sarcoma: a real-world retrospective study.巨乳腺叶状肿瘤和肉瘤的临床观点和结局:一项真实世界的回顾性研究。
BMC Cancer. 2023 Aug 28;23(1):801. doi: 10.1186/s12885-023-11279-2.
8
Prognostic factors of breast phyllodes tumors.乳腺叶状肿瘤的预后因素。
Histol Histopathol. 2023 Aug;38(8):865-878. doi: 10.14670/HH-18-600. Epub 2023 Feb 27.
9
Ki67 and P53 Expression in Relation to Clinicopathological Features in Phyllodes Tumour of the Breast.Ki67 和 P53 在乳腺叶状肿瘤中的表达与临床病理特征的关系。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2653-2659. doi: 10.31557/APJCP.2020.21.9.2653.
10
Width of margins in phyllodes tumors of the breast: the controversy drags on?-a systematic review and meta-analysis.乳腺叶状肿瘤的边缘宽度:争议仍在继续?——一项系统评价和荟萃分析。
Breast Cancer Res Treat. 2021 Jan;185(1):21-37. doi: 10.1007/s10549-020-05924-8. Epub 2020 Sep 15.